tiprankstipranks
NewsSmart PortfolioMarkets
Research Tools
Top Stocks
Top Smart Score Stocks
New
Analysts' Top StocksInsiders' Hot Stocks
Popular
Trending Stocks
Daily Feeds
Daily Stock RatingsDaily Insider Transactions
Comparisons
Stock ComparisonElectric Vehicles Stocks
New
Coronavirus Vaccine StocksFAANG Stocks
Popular
High Dividend StocksBitcoin Stocks
Screeners
Stock ScreenerPenny Stocks
New
Tools
Dividend Calculator
New
Smart Portfolio
My Portfolio
OverviewMy HoldingsMy Portfolio AnalysisCrowd Insights
My Watchlist
Stock WatchlistExpert Watchlist
Profile & Performance
My PerformanceMy Public Profile
New
Top Experts
Find & Follow Experts
My ExpertsExpert CenterTop Firms
Top Lists
Top 25 Wall Street AnalystsTop 25 Financial BloggersTop 25 Corporate InsidersTop 25 Hedge Fund ManagersTop Individual Investors
New
News
Categories
HomeMarket NewsTipRanks LabsIdeas & InsightsStock Analysis
Trending Topics
Coronavirus StocksDividend StocksPenny StocksFAANG Stocks
Calendars
Calendars & Events
Earnings CalendarsDividend CalendarsStock Market HolidaysIPO Calendar
About Us
About TipRanksEnterprise SolutionsBecome an AffiliateCareersContact Us
NewsSmart PortfolioMarketsNotifications
Welcome
LoginSign Up
NotificationsMy Watchlist
Research Tools
Top Smart Score StocksAnalysts' Top StocksInsiders' Hot StocksTrending Stocks
HomeMarket NewsStock AnalysisTipRanks LabsIdeas & Insights
Daily Stock RatingsDaily Insider Transactions
Expert CenterTop Wall Street AnalystsTop Financial BloggersTop Corporate InsidersTop Hedge Fund ManagersTop Individual InvestorsTop Performing Research Firms
Stock ComparisonAirline StocksBank StocksBiotech StocksBitcoin StocksCannabis StocksCasino StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksElectric Vehicles StocksFAANG StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksStay-At-Home StocksWallStreetBets StocksWork-From-Home Stocks
Stock ScreenerPenny Stocks
Dividend Calculator
Earnings CalendarsDividend CalendarsStock Market HolidaysIPO Calendar
Smart Portfolio
OverviewMy HoldingsMy Performance
My Portfolio AnalysisCrowd InsightsMy Public Profile
Account & More
LoginTipRanks PremiumPlans & Pricing
About TipRanksFAQAPI for Institutions
All News

BIIB Latest News

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), LivaNova (LIVN) and uniQure (QURE)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on...
Howard Kim
BIIBLIVNQURE
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (BIIB), Novavax (NVAX) and FibroGen (FGEN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB –...
Christine Brown
BIIBFGENNVAX
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on...
Brian Anderson
DGXDHRBIIB
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Plus Therapeutics (PSTV) and Applied Genetic Technologies (AGTC)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on...
Howard Kim
AGTCBIIBPSTV
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Biogen (BIIB)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in...
Brian Anderson
ABTBIIB
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), BioMarin Pharmaceutical (BMRN) and Icon (ICLR)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB –...
Brian Anderson
BIIBBMRNICLR
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Biomea Fusion (BMEA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on...
Christine Brown
BIIBBMEA
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Icon (ICLR)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in...
Jason Carr
BIIBICLR
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AVEO Pharma (AVEO), Biogen (BIIB) and Immunic (IMUX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh...
Jason Carr
AVEOBIIBIMUX
Analysts Offer Insights on Healthcare Companies: Icon (ICLR), Biogen (BIIB) and Spectrum Pharmaceuticals (SPPI)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on...
Catie Powers
BIIBICLRSPPI
Biogen Inks Deal with InnoCare on Orelabrutinib
Biogen Inks Deal with InnoCare on Orelabrutinib
Biogen (BIIB) recently inked a license and partnership agreement with InnoCare Pharma Limited. Biogen will gain exclusive rights...
Chandrima Sanyal
BIIB
Biogen’s Shares Fall as FDA Calls for Probe Into its Talks Before Alzheimer’s Drug Approval — Report
Biogen’s Shares Fall as FDA Calls for Probe Into its Talks Before Alzheimer’s Drug Approval — Report
According to a report published by Reuters, the U.S. Food and Drug Administration is seeking a federal investigation...
Richika Biyani
BIIB
Analysts Conflicted on These Healthcare Names: Biogen (BIIB) and Global Blood Therapeutics (GBT)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB –...
Brian Anderson
GBTBIIB
Analysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), Biohaven Pharmaceutical Holding Co (BHVN)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on...
Brian Anderson
BHVNBIIBVACC
Biogen Controversy could Detract from Stock Gains
Biogen Controversy could Detract from Stock Gains
Earlier this month, Biogen (BIIB) stock popped on news of the FDA (U.S. Food and Drug Administration) approving...
Thomas Niel
BIIB
Biogen: Alzheimer’s Expert Sees ‘Plenty of Patient Demand’ for Aduhelm
Biogen: Alzheimer’s Expert Sees ‘Plenty of Patient Demand’ for Aduhelm
It would be no exaggeration to say last week’s FDA decision to approve Aduhelm – Biogen’s (BIIB) treatment...
Marty Shtrubel
BIIB
SAGE Announces Positive Results for Zuranolone; Shares Plunge 19.3%
SAGE Announces Positive Results for Zuranolone; Shares Plunge 19.3%
Biopharmaceutical company Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB), a pioneer in neuroscience, together announced positive results...
Sheryl Sheth
BIIBSAGE
Is Biogen Stock a Buy Right Now? This Is What You Need to Know
Is Biogen Stock a Buy Right Now? This Is What You Need to Know
There’s a new FDA approved drug in town and an unexpected one at that. Going into Monday’s PDUFA...
Marty Shtrubel
BIIB
Biogen’s ADUHELM Receives Accelerated Approval from FDA; Shares Soar 38%
Biogen’s ADUHELM Receives Accelerated Approval from FDA; Shares Soar 38%
The global biotechnology company Biogen, Inc. (BIIB) and Eisai, Co. Ltd, a pharmaceutical company based in Japan, received...
Sheryl Sheth
BIIB
Will Biogen’s Alzheimer’s Drug Get the FDA’s Nod of Approval? Analyst Weighs In
Will Biogen’s Alzheimer’s Drug Get the FDA’s Nod of Approval? Analyst Weighs In
So far, Alzheimer’s disease is one puzzle the medical community has been unable to solve, and there are...
Marty Shtrubel
BIIB
Biogen Collaborates With Capsigen To Develop New Gene Therapies
Biogen Collaborates With Capsigen To Develop New Gene Therapies
Biogen (BIIB) has entered into a research collaboration with Capsigen Inc. to develop novel adeno-associated virus (AAV) capsids....
Kailas Salunkhe
BIIB
Biogen Revenue Drops 24% In 1Q; Shares Plunge 4%
Biogen Revenue Drops 24% In 1Q; Shares Plunge 4%
Biogen’s share price fell 4% on Thursday after the company reported first-quarter financial results and increased its full-year...
Neha Gupta
BIIB
Biogen’s TECFIDERA Approved In China For Treating Multiple Sclerosis
Biogen’s TECFIDERA Approved In China For Treating Multiple Sclerosis
Biogen Inc’s TECFIDERA has received approval from the National Medical Products Administration (NMPA) in China for treating relapsing...
Kailas Salunkhe
BIIB
Biogen’s 4Q Earnings Miss Street Estimates; Shares Fall 5.2%
Biogen’s 4Q Earnings Miss Street Estimates; Shares Fall 5.2%
Biogen’s shares dropped 5.2% on Feb. 3 as the biotech company’s fourth-quarter earnings fell short of analysts’ estimates....
Shrilekha Pethe
BIIB
Biogen Shares Gain 5.5% As FDA Extends Review Period For Alzheimer’s Drug
Biogen Shares Gain 5.5% As FDA Extends Review Period For Alzheimer’s Drug
Biogen shares were up by 5.5% on Jan. 29 after the pharma company announced that the U.S. Food...
Shrilekha Pethe
BIIB
Gilead Sciences or Biogen: Which Biotech Stock is a Better Pick for 2021?
Gilead Sciences or Biogen: Which Biotech Stock is a Better Pick for 2021?
An unprecedented pandemic did not stop the US stock market from finishing 2020 on a high note. The...
Sirisha Bhogaraju
BIIBGILD
Sage Therapeutics Gets $1.53B From Biogen in a Collaboration Deal
Sage Therapeutics Gets $1.53B From Biogen in a Collaboration Deal
Sage Therapeutics received $1.525 billion from Biogen under the earlier announced collaboration and license agreement to jointly develop...
Amit Singh
BIIBSAGE
Biogen Files For Japan Approval Of Potential Alzheimer Treatment; Street Says Hold
Biogen Files For Japan Approval Of Potential Alzheimer Treatment; Street Says Hold
Biogen has filed a new drug application to Japan’s regulator for the approval of aducanumab, its investigational treatment...
Sharon Wrobel
BIIB
Biogen Bombs at the FDA Panel; J.P. Morgan Weighs In
Biogen Bombs at the FDA Panel; J.P. Morgan Weighs In
By a vote of one for, eight against, and two abstaining, the U.S. Food and Drug Administration’s (FDA)...
TipRanks Team
BIIB
Biogen Rockets 44% On “Substantial Evidence” For Alzheimer’s Drug Approval
Biogen Rockets 44% On “Substantial Evidence” For Alzheimer’s Drug Approval
Shares of Biogen exploded 44% after staff at the US Food and Drug Administration (FDA) concluded in a...
Sharon Wrobel
BIIB
Biogen’s Tecfidera Now Faces Cipla Generic Launch; Analyst Wary
Biogen’s Tecfidera Now Faces Cipla Generic Launch; Analyst Wary
Global pharma Cipla has announced that it has received final approval for its generic therapeutic equivalent version of...
Harriet Lefton
BIIB
AbbVie vs Biogen: Which Drugmaker Scores A ‘Strong Buy’ Street Consensus?
AbbVie vs Biogen: Which Drugmaker Scores A ‘Strong Buy’ Street Consensus?
The COVID-19 pandemic has led to a wake-up call for governments, as they realize the significant investment required...
Sirisha Bhogaraju
ABBVBIIB
Biogen Spikes 10% On FDA Fast Review For Potential Alzheimer Treatment
Biogen Spikes 10% On FDA Fast Review For Potential Alzheimer Treatment
Shares in Biogen leaped 10% on Friday after the company said that the U.S. Food and Drug Administration...
Sharon Wrobel
BIIB
Biogen Rises 4% As Morgan Stanley Upgrades Stock To Buy
Biogen Rises 4% As Morgan Stanley Upgrades Stock To Buy
Shares in Biogen (BIIB) rose over 4% in early-market trading on Monday, after Morgan Stanley lifted the stock’s rating...
Amit Singh
BIIB
Biogen, Eisai Start New Phase 3 Trial For Pre-clinical Alzheimer’s Disease
Biogen, Eisai Start New Phase 3 Trial For Pre-clinical Alzheimer’s Disease
Biogen (BIIB), in collaboration with Eisai, and the Alzheimer’s Clinical Trials Consortium, has initiated a new global Phase...
Harriet Lefton
BIIB
Biogen: Approval Prospects for Aducanumab Amount to a Flip of a Coin, Says J.P. Morgan
Biogen: Approval Prospects for Aducanumab Amount to a Flip of a Coin, Says J.P. Morgan
Not all biotechs are highflyers in 2020. Despite some pharma companies’ elevated coronavirus driven valuations, some have had...
Marty Shtrubel
BIIB
Biogen Files FDA Application For Potential Alzheimer Treatment 
Biogen Files FDA Application For Potential Alzheimer Treatment 
Biogen Inc. (BIIB) announced that it has finally submitted the Biologics License Application (BLA) seeking approval by the...
Sharon Wrobel
BIIB